Skip to main content
Top
Published in: Hepatology International 4/2009

01-12-2009 | Original Article

Outcomes of patients with chest tube insertion for hepatic hydrothorax

Authors: Eric S. Orman, Anna S. F. Lok

Published in: Hepatology International | Issue 4/2009

Login to get access

Abstract

Purpose

Case reports and small case series have reported a high rate of complications associated with chest tube placement for hepatic hydrothorax. We describe the in-hospital and 3-month outcomes of patients who have had this procedure.

Methods

A retrospective medical record review was performed of all patients admitted to a tertiary care center over a 10-year period with a chest tube placed for hepatic hydrothorax. Demographic data and outcomes were collected and analyzed.

Results

Seventeen patients were identified; 12 were taking diuretics and 8 were taking multiple diuretics at the time of admission. MELD score was 14 (range = 7–34). During hospitalization, 16 had at least 1 and 12 had more than 1 complications. The most common complications were acute kidney injury (n = 11), pneumothorax (n = 7), and empyema (n = 5). Two patients died during the index admission and four others within 3 months of that admission. Six of seven patients who received TIPS survived.

Conclusions

Chest tube insertion for hepatic hydrothorax carries significant morbidity and mortality, with questionable benefit.
Literature
1.
go back to reference Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther 2004;20:271–279CrossRefPubMed Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther 2004;20:271–279CrossRefPubMed
2.
go back to reference Milanez de Campos JR, Andrade Filho LO, de Campos Werebe E, et al. Hepatic hydrothorax. Semin Respir Crit Care Med 2001;22:665–674CrossRefPubMed Milanez de Campos JR, Andrade Filho LO, de Campos Werebe E, et al. Hepatic hydrothorax. Semin Respir Crit Care Med 2001;22:665–674CrossRefPubMed
4.
go back to reference Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999;107:262–267CrossRefPubMed Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999;107:262–267CrossRefPubMed
5.
go back to reference Xiol X, Tremosa G, Castellote J, Gornals J, Lama C, Lopez C, et al. Liver transplantation in patients with hepatic hydrothorax. Transpl Int 2005;18:672–675CrossRefPubMed Xiol X, Tremosa G, Castellote J, Gornals J, Lama C, Lopez C, et al. Liver transplantation in patients with hepatic hydrothorax. Transpl Int 2005;18:672–675CrossRefPubMed
6.
go back to reference Feldman M, Friedman LS, Brandt LJ. Sleisenger & Fordtran’s gastrointestinal and liver disease. 8th ed. Philadelphia: W.B. Saunders; 2006 Feldman M, Friedman LS, Brandt LJ. Sleisenger & Fordtran’s gastrointestinal and liver disease. 8th ed. Philadelphia: W.B. Saunders; 2006
7.
go back to reference Liu LU, Haddadin HA, Bodian CA, Sigal SH, Korman JD, Bodenheimer HC Jr, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest 2004;126:142–148CrossRefPubMed Liu LU, Haddadin HA, Bodian CA, Sigal SH, Korman JD, Bodenheimer HC Jr, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest 2004;126:142–148CrossRefPubMed
8.
go back to reference Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001;13:529–534CrossRefPubMed Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001;13:529–534CrossRefPubMed
9.
go back to reference Jeffries MA, Kazanjian S, Wilson M, Punch J, Fontana RJ. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl 1998;4:416–423CrossRef Jeffries MA, Kazanjian S, Wilson M, Punch J, Fontana RJ. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl 1998;4:416–423CrossRef
10.
go back to reference Cerfolio RJ, Bryant AS. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg 2006;82:457–459CrossRefPubMed Cerfolio RJ, Bryant AS. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg 2006;82:457–459CrossRefPubMed
11.
go back to reference Ferrante D, Arguedas MR, Cerfolio RJ, Collins BG, van Leeuwen DJ. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol 2002;97:3172–3175CrossRefPubMed Ferrante D, Arguedas MR, Cerfolio RJ, Collins BG, van Leeuwen DJ. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol 2002;97:3172–3175CrossRefPubMed
12.
go back to reference Milanez de Campos JR, Filho LO, de Campos Werebe E, Setter H Jr, Fernandez A, Filomeno LT, et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest 2000;118:13–17CrossRefPubMed Milanez de Campos JR, Filho LO, de Campos Werebe E, Setter H Jr, Fernandez A, Filomeno LT, et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest 2000;118:13–17CrossRefPubMed
13.
go back to reference Borchardt J, Smirnov A, Metchnik L, Malnick S. Lesson of the week: treating hepatic hydrothorax. BMJ 2003;326:751–2CrossRefPubMed Borchardt J, Smirnov A, Metchnik L, Malnick S. Lesson of the week: treating hepatic hydrothorax. BMJ 2003;326:751–2CrossRefPubMed
14.
go back to reference Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986;81:566–567PubMed Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986;81:566–567PubMed
16.
go back to reference Ibrisim D, Cakaloglu Y, Akyuz F, Karadag A, Ozdil S, Besisik F, et al. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient. Scand J Gastroenterol 2006;41:862–865CrossRefPubMed Ibrisim D, Cakaloglu Y, Akyuz F, Karadag A, Ozdil S, Besisik F, et al. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient. Scand J Gastroenterol 2006;41:862–865CrossRefPubMed
17.
go back to reference Pfammatter R, Quattropani C, Reichen J, Goke B, Wagner AC. Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide. Eur J Gastroenterol Hepatol 2001;13:977–980CrossRefPubMed Pfammatter R, Quattropani C, Reichen J, Goke B, Wagner AC. Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide. Eur J Gastroenterol Hepatol 2001;13:977–980CrossRefPubMed
18.
go back to reference Chen A, Ho YS, Tu YC, Tang HS, Cheng TC. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol 1988;10:663–666PubMedCrossRef Chen A, Ho YS, Tu YC, Tang HS, Cheng TC. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol 1988;10:663–666PubMedCrossRef
19.
20.
go back to reference Karwa R, Woodis CB. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications. Ann Pharmacother 2009;43:692–699CrossRefPubMed Karwa R, Woodis CB. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications. Ann Pharmacother 2009;43:692–699CrossRefPubMed
21.
go back to reference Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the Consensus Conference of the International Ascites Club. Hepatology 2003;38:258–266CrossRefPubMed Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the Consensus Conference of the International Ascites Club. Hepatology 2003;38:258–266CrossRefPubMed
22.
go back to reference Wilputte JY, Goffette P, Zech F, Godoy-Gepert A, Geubel A. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients. Acta Gastroenterol Belg 2007;70:6–10PubMed Wilputte JY, Goffette P, Zech F, Godoy-Gepert A, Geubel A. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients. Acta Gastroenterol Belg 2007;70:6–10PubMed
23.
go back to reference Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002;13:385–390CrossRefPubMed Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002;13:385–390CrossRefPubMed
24.
go back to reference Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997;25:1366–1369CrossRefPubMed Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997;25:1366–1369CrossRefPubMed
25.
go back to reference Andrade RJ, Martin-Palanca A, Fraile JM, Alcantara R, Carmona C, Medina MC, et al. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol 1996;22:305–307CrossRefPubMed Andrade RJ, Martin-Palanca A, Fraile JM, Alcantara R, Carmona C, Medina MC, et al. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol 1996;22:305–307CrossRefPubMed
26.
go back to reference Conklin LD, Estrera AL, Weiner MA, Reardon PR, Reardon MJ. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg 2000;69:609–611CrossRefPubMed Conklin LD, Estrera AL, Weiner MA, Reardon PR, Reardon MJ. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg 2000;69:609–611CrossRefPubMed
27.
go back to reference Dumortier J, Lepretre J, Scalone O, Boillot O, Scoazec JY, Delafosse B, et al. Successful treatment of hepatic hydrothorax with octreotide. Eur J Gastroenterol Hepatol 2000;12:817–820CrossRefPubMed Dumortier J, Lepretre J, Scalone O, Boillot O, Scoazec JY, Delafosse B, et al. Successful treatment of hepatic hydrothorax with octreotide. Eur J Gastroenterol Hepatol 2000;12:817–820CrossRefPubMed
28.
go back to reference Haskal ZJ, Zuckerman J. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest 1994;106:1293–1295CrossRefPubMed Haskal ZJ, Zuckerman J. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest 1994;106:1293–1295CrossRefPubMed
Metadata
Title
Outcomes of patients with chest tube insertion for hepatic hydrothorax
Authors
Eric S. Orman
Anna S. F. Lok
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Hepatology International / Issue 4/2009
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-009-9136-z

Other articles of this Issue 4/2009

Hepatology International 4/2009 Go to the issue